Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Grab Holdings (GRAB) Stock on Dec. 25, 2025: Latest News, Analyst Forecasts, and Key Catalysts After Grab’s Robotaxi and Delivery-Robot Moves

Grab Holdings (GRAB) Stock on Dec. 25, 2025: Latest News, Analyst Forecasts, and Key Catalysts After Grab’s Robotaxi and Delivery-Robot Moves

Grab Holdings Limited is heading into the final week of 2025 with a familiar investor tug-of-war: the company’s core ride-hailing and deliveries engine is steadily improving profitability, while its newest headlines are about a very different future—autonomous driving, remote driving, and delivery robots. Add in renewed Grab–GoTo consolidation talk in Indonesia and a Singapore platform-fee increase starting Jan. 1, 2026, and GRAB stock has plenty of narrative fuel even on a holiday week. CNA
Rocket Lab Stock (RKLB) Surges Into 2026: Space Force Satellite Deal, Record 2025 Launches, Analyst Forecasts, and Key Risks

Rocket Lab Stock (RKLB) Surges Into 2026: Space Force Satellite Deal, Record 2025 Launches, Analyst Forecasts, and Key Risks

Dec. 25, 2025 — U.S. markets are closed for Christmas Day, but Rocket Lab Corporation is heading into the holiday break with unusual momentum. Over the past week, a major U.S. national security satellite award, a year-ending launch record, and a flurry of analyst note updates have pushed Rocket Lab stock into the center of the “space as defense” investing narrative.
Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer (PFE) Stock News, Forecasts and Analyst Outlook as of Dec. 25, 2025

Pfizer Inc. heads into Christmas Day with investors digesting a dense run of December headlines: a 2026 outlook that came in below Wall Street expectations, ongoing restructuring and cost-cutting, fresh U.S. drug-pricing initiatives that could reshape the industry’s economics, and multiple pipeline updates spanning oncology, immunology and cardiometabolic disease.
Intel Stock (INTC) News, Forecasts, and Analyst Outlook for Dec. 25, 2025: Nvidia’s 18A Pause, a U.S. Government Stake, and What Comes Next

Intel Stock (INTC) News, Forecasts, and Analyst Outlook for Dec. 25, 2025: Nvidia’s 18A Pause, a U.S. Government Stake, and What Comes Next

December 25, 2025 — Intel Corporation heads into the Christmas holiday with its turnaround narrative as loud as ever—and just as contested. After a volatile Christmas Eve session, Intel stock last traded at $36.18, down 0.56% on the day, with a $172B market cap and a 52-week range spanning roughly $18.59 to $44.02.
D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

D-Wave Quantum (QBTS) Stock News Today: CES 2026 Catalyst, Analyst Forecasts, and a Reality Check on Valuation

D-Wave Quantum Inc. heads into the Christmas break with the kind of chart that makes both momentum traders and risk managers reach for caffeine: a big 2025 run, a sharp December surge tied to fresh visibility at CES 2026, and then a quick pullback as the market digests insider-selling headlines and a valuation that’s sprinted far ahead of current revenue.
UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

December 25, 2025 — UiPath Inc. is closing out 2025 in the spotlight after a powerful, index-driven rally that pushed the automation software maker back onto investors’ year-end watchlists. With U.S. markets shut for Christmas Day, the conversation is now shifting from “why it moved” to “what the move changes”—for liquidity, ownership, and expectations heading into 2026. Reuters
1 398 399 400 401 402 609
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.